DHTRF (DRI Healthcare Trust) Piotroski F-Score: 4 (As of Jul. 04, 2026) — Near Median


DHTRF DRI Healthcare Trust DHTRF
33 GF Score
Price $12.70
GF Value $13.28
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is DRI Healthcare Trust Piotroski F-Score?

DRI Healthcare Trust DHTRF 33 Piotroski F-Score is 4 as of Jul. 04, 2026, which is at its 10-year median of 4.00. GuruFocus rates DHTRF with a GF Score™ of 33/100 and a GF Value™ of $13.28 (Fairly Valued). The stock has 4 warning signs investors should review. Among 981 Drug Manufacturers companies, DRI Healthcare Trust ranks worse than 60.86% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

DRI Healthcare Trust has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for DRI Healthcare Trust's Piotroski F-Score or its related term are showing as below:

DHTRF' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 4   Max: 7
Current: 4

During the past 5 years, the highest Piotroski F-Score of DRI Healthcare Trust was 7. The lowest was 3. And the median was 4.

DRI Healthcare Trust  (OTCPK:DHTRF) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


DRI Healthcare Trust Piotroski F-Score Related Terms


DRI Healthcare Trust Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for DRI Healthcare Trust's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DRI Healthcare Trust Piotroski F-Score Chart

DRI Healthcare Trust Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
N/A N/A 6.00 3.00 3.00

DRI Healthcare Trust Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.00 3.00 3.00 4.00

DHTRF vs ZTS, UTHR: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, DRI Healthcare Trust's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DRI Healthcare Trust Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DRI Healthcare Trust's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where DRI Healthcare Trust's Piotroski F-Score falls into.


DHTRF
33GF Score
DRI Healthcare Trust DHTRF
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 0.376 + -57.86 + 8.765 + -0.984 = $-49.7 Mil.
Cash Flow from Operations was 26.92 + -11.144 + 45.352 + 47.107 = $108.2 Mil.
Revenue was 31.961 + 38.908 + 52.251 + 40.652 = $163.8 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(962.045 + 967.257 + 909.046 + 942.819 + 916.384) / 5 = $939.5102 Mil.
Total Assets at the begining of this year (Mar25) was $962.0 Mil.
Long-Term Debt & Capital Lease Obligation was $456.1 Mil.
Total Assets was $916.4 Mil.
Total Liabilities was $482.8 Mil.
Net Income was -2.133 + -1.692 + 7.001 + -1.752 = $1.4 Mil.

Revenue was 32.733 + 32.139 + 45.672 + 30.247 = $140.8 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(903.449 + 874.067 + 884.079 + 984.867 + 962.045) / 5 = $921.7014 Mil.
Total Assets at the begining of last year (Mar24) was $903.4 Mil.
Long-Term Debt & Capital Lease Obligation was $306.9 Mil.
Total Assets was $962.0 Mil.
Total Liabilities was $441.9 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

DRI Healthcare Trust's current Net Income (TTM) was -49.7. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

DRI Healthcare Trust's current Cash Flow from Operations (TTM) was 108.2. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-49.703/962.045
=-0.0516639

ROA (Last Year)=Net Income/Total Assets (Mar24)
=1.424/903.449
=0.00157618

DRI Healthcare Trust's return on assets of this year was -0.0516639. DRI Healthcare Trust's return on assets of last year was 0.00157618. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

DRI Healthcare Trust's current Net Income (TTM) was -49.7. DRI Healthcare Trust's current Cash Flow from Operations (TTM) was 108.2. ==> 108.2 > -49.7 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=456.056/939.5102
=0.48541889

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=306.929/921.7014
=0.33300264

DRI Healthcare Trust's gearing of this year was 0.48541889. DRI Healthcare Trust's gearing of last year was 0.33300264. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

* Note that for banks and insurance companies, there's no Total Current Assets and Total Current Liabilities reported. Thus, we use Total Assets and Total Liabilities to calculate current ratio for banks and insurance companies.

Current Ratio (This Year: Mar26)=Total Assets/Total Liabilities
=916.384/482.752
=1.89825003

Current Ratio (Last Year: Mar25)=Total Assets/Total Liabilities
=962.045/441.923
=2.17695164

DRI Healthcare Trust's current ratio of this year was 1.89825003. DRI Healthcare Trust's current ratio of last year was 2.17695164. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

DRI Healthcare Trust's number of shares in issue this year was 55.039. DRI Healthcare Trust's number of shares in issue last year was 56.308. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

* Note that for banks and insurance companies, there's no Gross Profit reported. Thus, we use net income instead of gross profit and calculate Net Margin for this score.

Net Margin (This Year: TTM)=Net Income/Revenue
=-49.703/163.772
=-0.303489

Net Margin (Last Year: TTM)=Net Income/Revenue
=1.424/140.791
=0.01011428

DRI Healthcare Trust's net margin of this year was -0.303489. DRI Healthcare Trust's net margin of last year was 0.01011428. ==> Last year's net margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=163.772/962.045
=0.1702332

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=140.791/903.449
=0.15583724

DRI Healthcare Trust's asset turnover of this year was 0.1702332. DRI Healthcare Trust's asset turnover of last year was 0.15583724. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+0+0+1+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

DRI Healthcare Trust has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
DRI Healthcare Trust (DHTRF) has a Piotroski F-Score of 4 as of Jul. 04, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on DRI Healthcare Trust and its competitors. This is near median its historical median of 4.00. Over the past decade, DRI Healthcare Trust's Piotroski F-Score has ranged from 3.00 to 7.00. According to the industry distribution chart, DRI Healthcare Trust ranks #597 out of 981 companies in the Drug Manufacturers industry, placing it in the top 60.9%.
Is DRI Healthcare Trust's Piotroski F-Score too high?
DRI Healthcare Trust's current Piotroski F-Score of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 7.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. DRI Healthcare Trust's value of 4 is 20% below this industry median. Based on the distribution chart, DRI Healthcare Trust ranks #597 out of 981 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, DRI Healthcare Trust has a GF Score™ of 33/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DRI Healthcare Trust's Piotroski F-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, DRI Healthcare Trust ranks #597 out of 981 companies for Piotroski F-Score. This places DRI Healthcare Trust in the lower half of its industry. The industry median Piotroski F-Score is 5.00. DRI Healthcare Trust's value of 4 is 20% below this benchmark. Historically, DRI Healthcare Trust's own Piotroski F-Score has ranged from 3.00 to 7.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, DRI Healthcare Trust has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 981 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DRI Healthcare Trust's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on DRI Healthcare Trust and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DRI Healthcare Trust's current Piotroski F-Score is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DRI Healthcare Trust stock overvalued right now?
Based on GuruFocus' analysis, DRI Healthcare Trust (DHTRF) is currently considered Fairly Valued. The stock's GF Value™ is $13.28, compared to a current price of $12.70 — trading 4.4% below its estimated fair value. The current Piotroski F-Score is 4, which is near median its 10-year median of 4.00 and 20% below the Drug Manufacturers industry median of 5.00. DRI Healthcare Trust's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For DRI Healthcare Trust (DHTRF), the current Piotroski F-Score is 4 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DRI Healthcare Trust (DHTRF) Overvalued in 2026?

Based on GuruFocus' analysis, DRI Healthcare Trust stock appears to be undervalued. The current stock price of $12.70 is trading 4.4% below its estimated GF Value™ of $13.28. GuruFocus considers DRI Healthcare Trust to be Fairly Valued.

Key valuation signals for DHTRF:

  • Piotroski F-Score: 4 (near median its 10-year median of 4.00)
  • GF Value™: $13.28 vs. price of $12.70 (4.4% below fair value)
  • GF Score™: 33/100 with 4 warning signs
  • Industry Position: 20% below the Drug Manufacturers median (#597 of 981)

No single metric tells the full story. See the DHTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DRI Healthcare Trust Business Description

Other Exchanges DHT.UN:CanadaDHT.U:Canada
Address 100 King Street West, 1 First Canadian Place, Suite 6200, Toronto, ON, CAN, M5X 1B8
DRI Healthcare Trust is an open-ended trust that purchases royalty entitlements on products that address unmet medical needs, providing its unitholders with top-line exposure to a portfolio of therapeutics. Its portfolio comprises several royalty streams on products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically, it generates maximum royalty income from the sale of products underlying its royalty agreements in the United States, followed by other markets such as Japan, the European Union, and the rest of the world.
33GF Score

Get the complete analysis for DHTRF

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.70
Price
$13.28
GF Value